Ozempic, Wegovy among drugs selected for Medicare's price negotiations
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare Part-D for price negotiations, the next round of negotiations under the Inflation Reduction Act passed by President Joe Biden in 2022.
In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...
2d
The race is on for new drugs that suppress appetite, improve glucose regulation and can replace injections. But do they ...
Hosted on MSN18h
Will Ozempic, Wegovy be Affordable in the Near Future?Saving more, paying down debt and building wealth are top financial goals for many Americans. CNBC's Senior Personal Finance Correspondent Sharon Epperson and Anchor Kelly Evans share advice on how to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback